Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryan Case

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Phytochemistry|November 8, 2005
Phenolic glycosides and ionone glycoside from the stem of Sargentodoxa cuneataJun Chang, Ryan Case
Planta Medica|October 29, 2005
Cytotoxic phenolic constituents from the root of Actinidia chinensisJun Chang, Ryan Case
Frontiers in Neurology|November 28, 2022
The pharmacokinetics of continuous subcutaneous levodopa/carbidopa infusion: Findings from the ND0612 clinical development programPeter A LeWitt, Fabrizio Stocchi, David Arkadir, et al.
Parkinsonism & Related Disorders|October 7, 2021
ND0612 (levodopa/carbidopa for subcutaneous infusion) in patients with Parkinson's disease and motor response fluctuations: A randomized, placebo-controlled phase 2 studyNir Giladi, Tanya Gurevich, Ruth Djaldetti, et al.
Journal of Structural Biology|July 24, 2017
Hydration forces between aligned DNA helices undergoing B to A conformational change: In-situ X-ray fiber diffraction studies in a humidity and temperature controlled environmentRyan Case, Hauke Schollmeyer, Phillip Kohl, et al.
Contemporary Clinical Trials Communications|April 27, 2018
Design and outcomes of the Patient Centered Outcomes Research Institute coronary heart disease cohort studyChristianne L Roumie, Niral J Patel, Daniel Muñoz, et al.
Parkinsonism & Related Disorders|January 30, 2025
Long-term, continuous, subcutaneous levodopa/carbidopa infusion with ND0612 in Parkinson's disease: 3-year outcomes from the open-label BeyoND studyAaron L Ellenbogen, Werner Poewe, Alberto J Espay, et al.
SLAS Discovery : Advancing Life Sciences R & D|May 9, 2024
Creating a more strategic small molecule biophysical hit characterization workflowChristopher Fotsch, Debaleena Basu, Ryan Case, et al.
Cell Reports. Medicine|May 3, 2025
Characterization and comparative analysis of multifunctional natural killer cell engagers during antitumor responsesHang Lin, Ryan Case, Kathy Y Wei, et al.
Frontiers in Immunology|May 28, 2020
Engineered IL-21 Cytokine Muteins Fused to Anti-PD-1 Antibodies Can Improve CD8+ T Cell Function and Anti-tumor ImmunityShanling Shen, Gail Sckisel, Anupama Sahoo, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Phytochemistry|November 8, 2005
Phenolic glycosides and ionone glycoside from the stem of Sargentodoxa cuneataJun Chang, Ryan Case
Planta Medica|October 29, 2005
Cytotoxic phenolic constituents from the root of Actinidia chinensisJun Chang, Ryan Case
Frontiers in Neurology|November 28, 2022
The pharmacokinetics of continuous subcutaneous levodopa/carbidopa infusion: Findings from the ND0612 clinical development programPeter A LeWitt, Fabrizio Stocchi, David Arkadir, et al.
Parkinsonism & Related Disorders|October 7, 2021
ND0612 (levodopa/carbidopa for subcutaneous infusion) in patients with Parkinson's disease and motor response fluctuations: A randomized, placebo-controlled phase 2 studyNir Giladi, Tanya Gurevich, Ruth Djaldetti, et al.
Journal of Structural Biology|July 24, 2017
Hydration forces between aligned DNA helices undergoing B to A conformational change: In-situ X-ray fiber diffraction studies in a humidity and temperature controlled environmentRyan Case, Hauke Schollmeyer, Phillip Kohl, et al.
Contemporary Clinical Trials Communications|April 27, 2018
Design and outcomes of the Patient Centered Outcomes Research Institute coronary heart disease cohort studyChristianne L Roumie, Niral J Patel, Daniel Muñoz, et al.
Parkinsonism & Related Disorders|January 30, 2025
Long-term, continuous, subcutaneous levodopa/carbidopa infusion with ND0612 in Parkinson's disease: 3-year outcomes from the open-label BeyoND studyAaron L Ellenbogen, Werner Poewe, Alberto J Espay, et al.
SLAS Discovery : Advancing Life Sciences R & D|May 9, 2024
Creating a more strategic small molecule biophysical hit characterization workflowChristopher Fotsch, Debaleena Basu, Ryan Case, et al.
Cell Reports. Medicine|May 3, 2025
Characterization and comparative analysis of multifunctional natural killer cell engagers during antitumor responsesHang Lin, Ryan Case, Kathy Y Wei, et al.
Frontiers in Immunology|May 28, 2020
Engineered IL-21 Cytokine Muteins Fused to Anti-PD-1 Antibodies Can Improve CD8+ T Cell Function and Anti-tumor ImmunityShanling Shen, Gail Sckisel, Anupama Sahoo, et al.
Pageof 2